Biogen (BIIB) PT Lowered to $290 at Oppenheimer

March 21, 2019 12:42 PM
Oppenheimer analyst Jay Olson lowered the price target on Biogen (NASDAQ: BIIB) to $290.00 (from $375.00) while maintaining a Outperform ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles